← All indications
Anemia, Iron-Deficiency
Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.
Drugs by status
Approved for this indication (25)
- ferric derisomaltose
- docusate
- ferrous fumarate
- ferric carboxymaltose
- ferric maltol
- folic acid
- cyanocobalamin
- magnesium oxide
- niacin
- vitamin c
- magnesium sulfate
- nicotinamide
- thiamine
- biotin
- cupric sulfate pentahydrate
- zinc dichloride
- manganese sulfate
- pyridoxine
- ferric pyrophosphate citrate
- ferric sodium citrate
- riboflavin
- methylfolate
- zinc oxide
- ferrous cation
- ferrocholinate
Phase 4 trials (29)
- metronidazole
- iron
- procaine benzylpenicillin
- epoetin
- iron acetyl-transferase
- captafer
- chondroitin
- ferric citrate
- ferric sulfate
- ferrous glycine sulphate complex
- iron succinate
- fumaric acid esters
- iron dextran
- iron sucrose
- liposomal iron
- lactoferrin
- ferumoxytol
- cellulose
- iron colloid
- clarithromycin
- ferric hydroxide-polymaltose
- ferrous bisglycinate
- sodium chloride
- omeprazole
- hydroxocobalamin
- iron sulfate
- ferrous sulfate
- amino acid chelated iron
- Iron protein acetyl aspartate
Phase 3 trials (8)
Phase 2 trials (8)
Phase 1 trials (3)
Other trials (33)
- maltodextrin
- aminolevulinic acid
- bovine lactoferrin
- egg
- vitis vinifera
- ferro zinc
- gelatin
- albumin (Human)
- cobalamin
- inulin
- cow milk
- lactose
- red blood cells
- typhoid vi polysaccharide vaccine
- semaglutide
- acetylsalicylic acid
- inactivated japanese encephalitis vaccine
- coffee
- aspergillus oryzae
- moringa oleifera
- oleovital
- sodium phytate
- allogeneic blood cells
- guar gum
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- galactooligosaccharide
- ferric ammonium citrate
- reduced iron
- b multivitamins
- sorghum
- +3 more
Organizations
Organization Involved with Phase 4 Indications (106)
- Pierre Fabre
- Daiichi Sankyo
- Fresenius
- Pfizer
- Dialysis Clinic, Inc.
- J. Uriach and Company
- JW Pharmaceutical
- Laboratoire Innotech International
- PharmEvo Pvt Ltd
- Pharmacosmos
- Unipharm, Inc.
- Vifor Inc.
- Jordi Gol i Gurina Foundation
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Abdelwahed, Mai Mahmoud Mohamed, M.D.
- Mead Johnson
- Maisonneuve-Rosemont Hospital
- Maastricht University
- Medical University of Graz
- Ain Shams University
- Cairo University
- University of London
- Clinica Fabia Mater
- Gottfried Wilhelm Leibniz Universität Hannover
- Helen Keller International
- Hospital de Granollers
- Hospital Aleman
- Indiana University
- Kumamoto University
- +76 more
Organization Involved with Phase 3 Indications (64)
- Zeria Pharmaceutical
- Schwarz Pharma
- Sandoz
- GlaxoSmithKline
- GWT-TUD GmbH
- Hannover Clinical Trial Center GmbH
- INC Research
- Parexel
- Shield Therapeutics
- Casa Espirita Terra de Ismael
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Arizona
- Baylor University
- Boston University
- Duke University
- Ifakara Health Institute
- Mansoura University
- Norwegian University of Science and Technology
- RWTH Aachen University
- Stanford University
- Sykehuset Innlandet HF
- Texas Tech University
- University of Groningen
- University of Maryland
- University of Oslo
- University of Ottawa
- University of Pavia
- Denver Nephrologists, P.C.
- Prince of Songkla University
- Tel Aviv University
- +34 more
Organization Involved with Phase 2 Indications (26)
- Novartis
- MegaPro Biomedical Co. Ltd.
- Medical Research Council
- Iowa State University
- New York University
- The Guthrie Clinic
- University of Ghana
- University of Michigan
- Wayne State University
- University of Cambridge
- University of Colorado, Denver
- University of Minnesota
- Medical University of Vienna
- Rockwell Medical Inc
- Government of China
- Medical Research Council, The Gambia
- University of Wisconsin
- Wellcome Trust
- Humboldt University
- University of Colorado
- Wexham Park Hospital
- National Nutrition Agency, The Gambia
- Government of Poland
- Chinese Academy of Medical Sciences
- North Shore University Hospital
- University of Veterinary and Animal Sciences, Lahore
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (67)
- Unilever
- Beingmate Baby & Child Food Co Ltd .
- Danone Research
- DSM
- Probi AB
- Westat
- American National Red Cross
- Build Healthy India Movement
- Medical Research Council, South Africa
- Swiss Federal Institute of Technology
- United States Department of Agriculture
- Blood Center of Wisconsin
- Cornell University
- Dartmouth University
- Federal University of Minas Gerais
- Hacettepe University
- Hiroshima University
- Johns Hopkins University
- Mahidol University
- New York Blood Center
- Northwestern University
- Sao Jose do Rio Preto University
- Sichuan University
- Tanta University
- University of East Anglia
- University of Malaya
- University of Milan
- University of Palermo
- University of Reading
- University of Bergen
- +37 more